Ovarian Cancer Clinical Trial

Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

Summary

This study evaluates blood samples and compares levels of metabolites (levels of vitamins, carbohydrates, proteins, etc., that are in the blood), before and after the plasma exchange in patients scheduled to receive immunotherapy for their ovarian cancer. The information gained from this study may help researchers better understand the side effects from each treatment and possibly lessen those side effects for future treatments.

View Full Description

Full Description

PRIMARY OBJECTIVE:

I. To determine the extent to which PARP inhibitor (PARPi) treatment reduces systemic levels of mesenchymal stem cell (MSC)-derived cancer support factors in patients with cancer.

OUTLINE:

Patients undergo collection of blood samples prior to drug initiation, weekly thereafter for the first month of therapy, monthly for the first month, and at disease progression or after cessation of treatment to monitor for toxicity. Blood samples are analyzed. Patients' medical charts are also reviewed to determine outcomes after PARP inhibition.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adults
Patients with ovarian cancer starting PARP inhibitor treatment

Exclusion Criteria:

Patients unwilling to return for blood draws, patients unwilling to continue PARP inhibitor treatment for at least one month

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

15

Study ID:

NCT04917744

Recruitment Status:

Active, not recruiting

Sponsor:

Mayo Clinic

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Mayo Clinic in Rochester
Rochester Minnesota, 55905, United States

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

15

Study ID:

NCT04917744

Recruitment Status:

Active, not recruiting

Sponsor:


Mayo Clinic

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.